परिशिष्ट

Author guidelines: Volume 5 Issue 5

• अमूर्त

परिशिष्ट

Acknowledgment: Volume 5 Issue 5

• अमूर्त

परिशिष्ट

Indices: Volume 5 Issue 5

• अमूर्त

परिशिष्ट

Glossary: Volume 5 Issue 5

• अमूर्त

परिप्रेक्ष्य

HIV drug policies and South markets: settling controversies

Daniele Dionisio, Claudio Fabbri and Daniela Messeri

• अमूर्त

शोध आलेख

Study of the extraction, purification and antidiabetic potential of ursolic acid from Cornus officinalis Sieb. et Zucc.

Dawei Gao, Na Li, Qingwang Li, Jian Li, Zengsheng Han, Yusheng Fan and Zhiwei Liu

• अमूर्त

समीक्षा लेख

Management of pediatric multiple sclerosis

Lauren B Krupp

• अमूर्त

समीक्षा लेख

Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis

Meghann Teague Getts, Daniel R Getts, Adam P Kohm and Stephen D Miller

• अमूर्त

समीक्षा लेख

Pharmacogenomics in multiple sclerosis: getting the right medicine to the right patient

Manuel Comabella

• अमूर्त

समीक्षा लेख

Novel designs for clinical trials in multiple sclerosis: another excursion to Sirenum scopuli?

Stacey S Cofield and Gary R Cutter

• अमूर्त

औषधि मूल्यांकन

Dirucotide (MBP8298) for the treatment of multiple sclerosis

Clyde Markowitz

• अमूर्त

औषधि मूल्यांकन

Dabigatran etexilate: an oral direct thrombin inhibitor

Ola E Dahl

• अमूर्त

औषधि मूल्यांकन

Desmopressin for the treatment of adult nocturia

Hashim Hashim and Paul Abrams

• अमूर्त

प्राथमिकता पेपर मूल्यांकन

Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis

Yoshiyuki Ohsugi

• अमूर्त

परिशिष्ट

Bulletin Board: Volume 5 Issue 5

• अमूर्त

संपादकीय

What is the optimal vitamin D level for health?

Edward Giovannucci

• अमूर्त

अनुसंधान की मुख्य विशेषताएं

Highlights from the latest articles in multiple sclerosis

• अमूर्त

साक्षात्कार

Dr Leslie Weiner speaks to Charlotte Barker, Commissioning Editor

Leslie P Weiner

• अमूर्त

समाचार और दृश्य

Multiple sclerosis therapeutics

• अमूर्त

संपादकीय

What are new therapies teaching us about the immunology of multiple sclerosis?

Michael K Racke and Amy E Lovett-Racke

• अमूर्त

प्रस्तावना

Multiple sclerosis therapeutics: opportunities, strategies and challenges

Richard A Rudick

• अमूर्त